<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13(21)</volume><submitter>Girolami I</submitter><pubmed_abstract>The management of head and neck squamous cell carcinoma (HNSCC) relies heavily on TNM staging and WHO histologic grading; however, in recent years, the analysis of prognostic markers expressed in the tumor stroma has gained attention. The tumor-stroma ratio (TSR) quantifies the proportion of tumor tissue relative to the surrounding stromal tissue; it is assessed with the percentage of stromal tissue within the tumor area, with a cutoff point of 50% being widely used to discriminate high-stroma cancer. In this systematic review and meta-analysis, we investigated the potential prognostic role of the TSR in HNSCC. After a literature screening, 24 studies dealing with the TSR and survival outcomes were included. The TSR showed a significant association with overall survival (OS) in both unadjusted and adjusted measures (RR 2.04, CI 1.57-2.65, &lt;i>p&lt;/i> &lt; 0.01; HR 2.36 CI 1.89-2.94, &lt;i>p&lt;/i> &lt; 0.00001), with an even stronger prognostic potential in oral cavity/oral tongue cancers (RR 2.44 CI 1.84-3.22, &lt;i>p&lt;/i> &lt; 0.00001). The TSR also showed prognostic value when dealing with cancer-specific survival and was associated with a reduction in disease-free survival (DFS). In particular, the TSR also retained its prognostic role in terms of DFS when specifically considering early-stage cancers in both unadjusted and adjusted analyses (RR 1.81 CI 1.57-2.10, &lt;i>p&lt;/i> &lt; 0.00001; HR 2.09 CI 1.58-2.76, &lt;i>p&lt;/i> &lt; 0.00001). Therefore, we conclude that the TSR is a reliable prognostic marker that is easy to assess in routine histological slides and can be effectively implemented in the routine evaluation of HNSCC.</pubmed_abstract><journal>Cells</journal><pagination>1772</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11545263</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Prognostic Significance of Tumor-Stroma Ratio (TSR) in Head and Neck Squamous Cell Carcinoma: Systematic Review and Meta-Analysis.</pubmed_title><pmcid>PMC11545263</pmcid><pubmed_authors>Abousiam M</pubmed_authors><pubmed_authors>Girolami I</pubmed_authors><pubmed_authors>Damiani D</pubmed_authors><pubmed_authors>Gazzini L</pubmed_authors><pubmed_authors>Hanspeter E</pubmed_authors><pubmed_authors>Negro R</pubmed_authors><pubmed_authors>Calabrese L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Prognostic Significance of Tumor-Stroma Ratio (TSR) in Head and Neck Squamous Cell Carcinoma: Systematic Review and Meta-Analysis.</name><description>The management of head and neck squamous cell carcinoma (HNSCC) relies heavily on TNM staging and WHO histologic grading; however, in recent years, the analysis of prognostic markers expressed in the tumor stroma has gained attention. The tumor-stroma ratio (TSR) quantifies the proportion of tumor tissue relative to the surrounding stromal tissue; it is assessed with the percentage of stromal tissue within the tumor area, with a cutoff point of 50% being widely used to discriminate high-stroma cancer. In this systematic review and meta-analysis, we investigated the potential prognostic role of the TSR in HNSCC. After a literature screening, 24 studies dealing with the TSR and survival outcomes were included. The TSR showed a significant association with overall survival (OS) in both unadjusted and adjusted measures (RR 2.04, CI 1.57-2.65, &lt;i>p&lt;/i> &lt; 0.01; HR 2.36 CI 1.89-2.94, &lt;i>p&lt;/i> &lt; 0.00001), with an even stronger prognostic potential in oral cavity/oral tongue cancers (RR 2.44 CI 1.84-3.22, &lt;i>p&lt;/i> &lt; 0.00001). The TSR also showed prognostic value when dealing with cancer-specific survival and was associated with a reduction in disease-free survival (DFS). In particular, the TSR also retained its prognostic role in terms of DFS when specifically considering early-stage cancers in both unadjusted and adjusted analyses (RR 1.81 CI 1.57-2.10, &lt;i>p&lt;/i> &lt; 0.00001; HR 2.09 CI 1.58-2.76, &lt;i>p&lt;/i> &lt; 0.00001). Therefore, we conclude that the TSR is a reliable prognostic marker that is easy to assess in routine histological slides and can be effectively implemented in the routine evaluation of HNSCC.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Oct</publication><modification>2025-04-18T14:06:22.47Z</modification><creation>2025-04-04T18:55:58.814Z</creation></dates><accession>S-EPMC11545263</accession><cross_references><pubmed>39513879</pubmed><doi>10.3390/cells13211772</doi></cross_references></HashMap>